Literature DB >> 21442239

Mixed germ cell tumor and hemangioblastoma in the cerebellum: report of a rare coexistence.

Tomotsugu Ichikawa1, Shuji Hamazaki, Naoto Sakai, Yoshiro Otsuki, Takafumi Wataya, Hirokazu Kambara, Taro Shuin, Isao Date.   

Abstract

We report a case of a cerebellar tumor consisting of a mixed germ cell tumor (GCT) and a hemangioblastoma. A 22-year-old man presented with myoclonus and cerebellar ataxia. Magnetic resonance imaging showed a tumor mass in the left cerebellar hemisphere. The tumor was totally removed, and the histological diagnosis was an undetermined neoplasm. Ten months later, the patient returned with cerebellar hemorrhage at the site of the previous tumor. An emergency craniotomy was performed, and a tumor mass adjacent to the hematoma was resected. Microscopic examination revealed a mixed GCT consisting of a germinoma, choriocarcinoma, and mature teratomatous component. An area of hemangioblastoma was also found in the same tumor mass. A retrospective examination of the histological sample from the first operation indicated a germinoma. A primary GCT of the posterior fossa is very rare, and there are no other reports of the coexistence of a GCT and a hemangioblastoma. A metastatic GCT lesion of extracranial origin should be considered when the intracranial GCT is non-germinomatous and arises in an unusual site. The most probable hypothesis for the histogenesis of this case was a hemangioblastoma complicated by a "tumor-to-tumor" metastatic lesion of testicular GCT with "burnout" of the primary site.

Entities:  

Mesh:

Year:  2011        PMID: 21442239     DOI: 10.1007/s10014-011-0031-7

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  1 in total

1.  Radiographic occult cerebellar germinoma presenting with progressive ataxia and cranial nerve palsy.

Authors:  Noriaki Minami; Kazuhiro Tanaka; Hidehito Kimura; Takanori Hirose; Tatsuya Mori; Masahiro Maeyama; Hiroaki Sekiya; Takeshi Uenaka; Satoshi Nakamizo; Hiroaki Nagashima; Katsu Mizukawa; Tomoo Itoh; Takashi Sasayama; Eiji Kohmura
Journal:  BMC Neurol       Date:  2016-01-12       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.